Literature DB >> 23047250

Dietary agonists of TRPV1 inhibit gastric acid secretion in mice.

Hirokuni Okumi1, Kimihito Tashima, Kenjiro Matsumoto, Takao Namiki, Katsutoshi Terasawa, Syunji Horie.   

Abstract

Capsaicin and 6-gingerol, pungent components of chilli pepper and ginger, are known as dietary agonists of transient receptor potential vanilloid-1. Transient receptor potential vanilloid-1 nerve fibers are recognized to play a role in gastric mucosal integrity in rats. In the present studies, we examined the acute effects of peroral administration of capsaicin and 6-gingerol on gastric acid secretion in conscious mice. These agents were given p. o. 30 min before the pylorus was ligated. Oral administration of capsaicin (1.0-100 mg/kg) or 6-gingerol (1.5-50 mg/kg) significantly and dose-dependently inhibited basal acid secretion. Pretreatment with BCTC, a transient receptor potential vanilloid-1 antagonist, significantly reversed the reduced basal acid secretion by capsaicin or 6-gingerol. The combination of the lowest doses of capsaicin and 6-gingerol markedly inhibited basal acid secretion in conscious mice and this was also significantly reversed by BCTC. Moreover, the combination of the maximal dose of capsaicin and 6-gingerol inhibited basal acid secretion only to the level of a single administration of the maximal dose of capsaicin. These results suggest that the combination of capsaicin and 6-gingerol has an additive effect on the inhibition of gastric acid secretion through activation of transient receptor potential vanilloid-1. In separate experiments, intraduodenal administration of either capsaicin (30 mg/kg) or 6-gingerol (15 mg/kg), whose doses were observed to have a significant inhibitory effect by oral administration, tended to inhibit basal acid secretion compared with the vehicle. These results suggest that the combination of capsaicin and 6-gingerol has an additive effect on inhibition of gastric acid secretion through activation of transient receptor potential vanilloid-1, and oral administration of transient receptor potential vanilloid-1 agonists directly stimulates transient receptor potential vanilloid-1 in the gastric lumen, resulting in a potent reduction of gastric acid secretion. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047250     DOI: 10.1055/s-0032-1315387

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  5 in total

1.  Calorie restriction protects against apoptosis, mitochondrial oxidative stress and increased calcium signaling through inhibition of TRPV1 channel in the hippocampus and dorsal root ganglion of rats.

Authors:  Fatih Gültekin; Mustafa Nazıroğlu; Hasan Basri Savaş; Bilal Çiğ
Journal:  Metab Brain Dis       Date:  2018-07-16       Impact factor: 3.584

Review 2.  Transient receptor potential channels as targets for phytochemicals.

Authors:  Louis S Premkumar
Journal:  ACS Chem Neurosci       Date:  2014-06-24       Impact factor: 4.418

3.  Ephedra Herb extract activates/desensitizes transient receptor potential vanilloid 1 and reduces capsaicin-induced pain.

Authors:  Shunsuke Nakamori; Jun Takahashi; Sumiko Hyuga; Toshiko Tanaka-Kagawa; Hideto Jinno; Masashi Hyuga; Takashi Hakamatsuka; Hiroshi Odaguchi; Yukihiro Goda; Toshihiko Hanawa; Yoshinori Kobayashi
Journal:  J Nat Med       Date:  2016-09-08       Impact factor: 2.343

4.  Clinical Evaluation of the Use of Ginger Extract in the Preventive Management of Motion Sickness.

Authors:  Carlos Pereira Nunes; Claudio de Campos Rodrigues; Carlos Alfredo Franco Cardoso; Natasha Cytrynbaum; Renato Kaufman; Helio Rzetelna; Gerson Goldwasser; Alessandra Santos; Lisa Oliveira; Mauro Geller
Journal:  Curr Ther Res Clin Exp       Date:  2020-06-15

Review 5.  The Role of Transient Receptor Potential Vanilloid 1 in Common Diseases of the Digestive Tract and the Cardiovascular and Respiratory System.

Authors:  Qian Du; Qiushi Liao; Changmei Chen; Xiaoxu Yang; Rui Xie; Jingyu Xu
Journal:  Front Physiol       Date:  2019-08-21       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.